MICHELLE DUDLEY: Open Payments
NPI 1104276708 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 56 payments from 16 companies in 2025. Trend: 2023 $2,035 · 2024 $2,385 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $251 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $131 |
| Janssen Biotech, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| Madrigal Pharmaceuticals | 3 | $70 |
| Ardelyx, Inc. | 4 | $69 |
| Ipsen Biopharmaceuticals, Inc | 3 | $68 |
| Lilly USA, LLC | 2 | $39 |
| Gilead Sciences, Inc. | 2 | $38 |
Products named: XIFAXAN, TREMFYA, LINZESS, RINVOQ, ENTYVIO, VOQUEZNA, SKYRIZI, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
